Arnold Devous, MD, MPH, FACPM
NPI: 1073566733
Total Payments
$46,011
2019 Payments
$20,955
Companies
3
Transactions
92
Payment Breakdown by Category
Other$34,150 (74.2%)
Travel$10,272 (22.3%)
Food & Beverage$1,573 (3.4%)
Education$16.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34,150 | 18 | 74.2% |
| Travel and Lodging | $10,272 | 22 | 22.3% |
| Food and Beverage | $1,573 | 49 | 3.4% |
| Education | $16.40 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $45,953 | 90 | $0 (2019) |
| Medtronic MiniMed, Inc. | $45.93 | 1 | $0 (2019) |
| Dexcom, Inc. | $12.39 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $20,955 | 31 | AstraZeneca Pharmaceuticals LP ($20,897) |
| 2018 | $24,789 | 48 | AstraZeneca Pharmaceuticals LP ($24,789) |
| 2017 | $266.87 | 13 | AstraZeneca Pharmaceuticals LP ($266.87) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/24/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $296.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $160.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $131.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $61.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $45.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $39.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $203.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $154.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/23/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/02/2019 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $45.93 | General |
| Category: Durable Pump | ||||||
| 03/19/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/22/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/22/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $6.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/21/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $1,615.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/21/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $157.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/21/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $53.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/21/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $35.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/27/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
About Arnold Devous, MD, MPH, FACPM
Arnold Devous, MD, MPH, FACPM is a Public Health & General Preventive Medicine healthcare provider based in Billings, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073566733.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Arnold Devous, MD, MPH, FACPM has received a total of $46,011 in payments from pharmaceutical and medical device companies, with $20,955 received in 2019. These payments were reported across 92 transactions from 3 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($34,150).
Ad
Practice Information
- Specialty Public Health & General Preventive Medicine
- Other Specialties Addiction Medicine, Addiction Medicine
- Location Billings, MT
- Active Since 05/17/2006
- Last Updated 10/26/2011
- Taxonomy Code 2083P0901X
- Entity Type Individual
- NPI Number 1073566733
Products in Payments
- FARXIGA (Drug) $45,925
- Minimed 670G System (Device) $45.93
- BYDUREON (Drug) $28.59
- DEXCOM CGM (Device) $12.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.